133 related articles for article (PubMed ID: 9388823)
1. The use of pamidronate in PTHrP associated hypercalcaemia in infancy.
Buckmaster A; Rodda C; Cowell CT; Ogle G; Dorney S
J Pediatr Endocrinol Metab; 1997; 10(3):301-4. PubMed ID: 9388823
[No Abstract] [Full Text] [Related]
2. Parathyroid hormone-related protein and response to pamidronate in tumour-induced hypercalcaemia.
Gurney H; Grill V; Martin TJ
Lancet; 1993 Jun; 341(8861):1611-3. PubMed ID: 8099988
[TBL] [Abstract][Full Text] [Related]
3. Parathyroid hormone-related protein(50-69) and response to pamidronate therapy for tumour-induced hypercalcaemia.
Dodwell DJ; Abbas SK; Morton AR; Howell A
Eur J Cancer; 1991; 27(12):1629-33. PubMed ID: 1782072
[TBL] [Abstract][Full Text] [Related]
4. Direct and indirect assessment of the parathyroid hormone response to pamidronate therapy in Paget's disease of bone and hypercalcaemia of malignancy.
Fraser WD; Logue FC; Gallacher SJ; O'Reilly DS; Beastall GH; Ralston SH; Boyle IT
Bone Miner; 1991 Feb; 12(2):113-21. PubMed ID: 1849762
[TBL] [Abstract][Full Text] [Related]
5. Bisphosphonate treatment of tumor-induced hypercalcemia in a toddler: case report and review of related literature.
Mastrandrea LD; Albini CH
Endocr Pract; 2006; 12(6):670-5. PubMed ID: 17229665
[TBL] [Abstract][Full Text] [Related]
6. Rhabdoid tumor of the kidney with humoral hypercalcemia and parathyroid hormone-related protein production.
Papadakis V; Vlachopapadopoulou EA; Levine L
Med Pediatr Oncol; 1995 Feb; 24(2):133-6. PubMed ID: 7990762
[TBL] [Abstract][Full Text] [Related]
7. Circulating PTH and PTHrP levels before and after treatment of tumor induced hypercalcemia with Pamidronate Disodium (APD).
Grill V; Murray RM; Ho PW; Santamaria JD; Pitt P; Potts C; Jerums G; Martin TJ
J Clin Endocrinol Metab; 1992 Jun; 74(6):1468-70. PubMed ID: 1592895
[TBL] [Abstract][Full Text] [Related]
8. Response to intravenous bisphosphonate therapy in hypercalcaemic patients with and without bone metastases: the role of parathyroid hormone-related protein.
Walls J; Ratcliffe WA; Howell A; Bundred NJ
Br J Cancer; 1994 Jul; 70(1):169-72. PubMed ID: 8018531
[TBL] [Abstract][Full Text] [Related]
9. Pamidronate treatment in patients with tumor-associated hypercalcemia: pharmacological effects and pharmacokinetics.
Oiso Y; Tomita A; Hasegawa H; Ariyoshi Y; Niinomi M; Yamamoto M; Takano T; Sakiyama N
Endocr J; 1994 Dec; 41(6):655-61. PubMed ID: 7704089
[TBL] [Abstract][Full Text] [Related]
10. Hypercalcemia and local production of parathyroid hormone-related protein by a perisellar rhabdomyosarcoma after remote pituitary irradiation.
Florez JC; Burton DW; Arnell PM; Deftos LJ; Klibanski A
Endocr Pract; 2005; 11(3):184-9. PubMed ID: 16239205
[TBL] [Abstract][Full Text] [Related]
11. Prolonged remission of hypercalcaemia due to parathyroid carcinoma with pamidronate.
Newrick PG; Braatvedt GD; Webb AJ; Sheffield E; Corrall RJ
Postgrad Med J; 1994 Mar; 70(821):231-2. PubMed ID: 8183761
[TBL] [Abstract][Full Text] [Related]
12. Pamidronate (Aredia, Ciba) in malignant hypercalcaemia.
MacConnachie AM
Intensive Crit Care Nurs; 1997 Feb; 13(1):58-9. PubMed ID: 9095884
[TBL] [Abstract][Full Text] [Related]
13. Effects of treatment of malignancy-associated hypercalcemia on serum parathyroid hormone-related protein.
Budayr AA; Zysset E; Jenzer A; Thiébaud D; Ammann P; Rizzoli R; Jaquet-Müller F; Bonjour JP; Gertz B; Burckhardt P
J Bone Miner Res; 1994 Apr; 9(4):521-6. PubMed ID: 8030440
[TBL] [Abstract][Full Text] [Related]
14. Dose of bisphosphonate for hypercalcaemia of malignancy.
Morton AR; Friefeld J; Halperin F
Lancet; 1990 Jun; 335(8703):1469-70. PubMed ID: 1972245
[No Abstract] [Full Text] [Related]
15. Rhabdoid tumour of the kidney: a diagnostic challenge and a fatal outcome.
Desai SR; Upadhyay V
Pediatr Surg Int; 2000; 16(5-6):449-50. PubMed ID: 10955590
[TBL] [Abstract][Full Text] [Related]
16. Hypercalcemia in malignant paraganglioma due to parathyroid hormone-related protein.
Loh K; Matthay KK; Hoover M; Bracho FA; Cortez AB; Conte FA; Albanese CT; Miller TR; Price DC; Flores AJ; Kaviani A; Shoback D
Horm Res; 1998; 50(4):217-21. PubMed ID: 9838243
[TBL] [Abstract][Full Text] [Related]
17. Vitamin D intoxication and hypercalcaemia in an infant treated with pamidronate infusions.
Ezgu FS; Buyan N; Gündüz M; Tümer L; Okur I; Hasanoglu A
Eur J Pediatr; 2004 Mar; 163(3):163-5. PubMed ID: 14714183
[TBL] [Abstract][Full Text] [Related]
18. Parathyroid hormone-related protein (PTHrP) does not regulate 1,25-dihydroxyvitamin D serum levels in hypercalcemia of malignancy.
Schilling T; Pecherstorfer M; Blind E; Leidig G; Ziegler R; Raue F
J Clin Endocrinol Metab; 1993 Mar; 76(3):801-3. PubMed ID: 8445039
[TBL] [Abstract][Full Text] [Related]
19. Hypercalcaemia in osteogenesis imperfecta treated with pamidronate.
Williams CJ; Smith RA; Ball RJ; Wilkinson H
Arch Dis Child; 1997 Feb; 76(2):169-70. PubMed ID: 9068314
[TBL] [Abstract][Full Text] [Related]
20. Malignant hypercalcaemia in pregnancy and antenatal administration of intravenous pamidronate.
Illidge TM; Hussey M; Godden CW
Clin Oncol (R Coll Radiol); 1996; 8(4):257-8. PubMed ID: 8871006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
